[HTML][HTML] Striatal dopamine neurotransmission: regulation of release and uptake
Dopamine (DA) transmission is governed by processes that regulate release from axonal
boutons in the forebrain and the somatodendritic compartment in midbrain, and by …
boutons in the forebrain and the somatodendritic compartment in midbrain, and by …
Toxicity of amphetamines: an update
Amphetamines represent a class of psychotropic compounds, widely abused for their
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …
Mechanisms of neurotransmitter release by amphetamines: a review
D Sulzer, MS Sonders, NW Poulsen, A Galli - Progress in neurobiology, 2005 - Elsevier
Amphetamine and substituted amphetamines, including methamphetamine,
methylphenidate (Ritalin), methylenedioxymethamphetamine (ecstasy), and the herbs khat …
methylphenidate (Ritalin), methylenedioxymethamphetamine (ecstasy), and the herbs khat …
New insights into the mechanism of action of amphetamines
AE Fleckenstein, TJ Volz, EL Riddle… - Annu. Rev …, 2007 - annualreviews.org
Amphetamine is a psychostimulant commonly used to treat several disorders, including
attention deficit, narcolepsy, and obesity. Plasmalemmal and vesicular monoamine …
attention deficit, narcolepsy, and obesity. Plasmalemmal and vesicular monoamine …
Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease
CL German, MG Baladi, LM McFadden… - Pharmacological …, 2015 - ASPET
Dopamine (DA) plays a well recognized role in a variety of physiologic functions such as
movement, cognition, mood, and reward. Consequently, many human disorders are due, in …
movement, cognition, mood, and reward. Consequently, many human disorders are due, in …
Neurotoxicity of methamphetamine and 3, 4-methylenedioxymethamphetamine
LE Halpin, SA Collins, BK Yamamoto - Life sciences, 2014 - Elsevier
Amphetamines are a class of psychostimulant drugs that are widely abused for their
stimulant, euphoric, empathogenic and hallucinogenic properties. Many of these effects …
stimulant, euphoric, empathogenic and hallucinogenic properties. Many of these effects …
Pharmacology of drugs used as stimulants
JR Docherty, HA Alsufyani - The Journal of Clinical …, 2021 - Wiley Online Library
Psychostimulant, cardiovascular, and temperature actions of stimulants involve adrenergic
(norepinephrine), dopaminergic (dopamine), and serotonergic (serotonin) pathways …
(norepinephrine), dopaminergic (dopamine), and serotonergic (serotonin) pathways …
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage …
J Lotharius, J Falsig, J van Beek, S Payne… - Journal of …, 2005 - Soc Neuroscience
Models of Parkinson's disease (PD) based on selective neuronal death have been used to
study pathogenic mechanisms underlying nigral cell death and in some instances to …
study pathogenic mechanisms underlying nigral cell death and in some instances to …
Trace amines and the trace amine-associated receptor 1: pharmacology, neurochemistry, and clinical implications
Y Pei, A Asif-Malik, JJ Canales - Frontiers in neuroscience, 2016 - frontiersin.org
Biogenic amines are a collection of endogenous molecules that play pivotal roles as
neurotransmitters and hormones. In addition to the “classical” biogenic amines resulting …
neurotransmitters and hormones. In addition to the “classical” biogenic amines resulting …
Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons
TS Guillot, GW Miller - Molecular neurobiology, 2009 - Springer
Vesicular monoamine transporters (VMATs) are responsible for the packaging of
neurotransmitters such as dopamine, serotonin, norepinephrine, and epinephrine into …
neurotransmitters such as dopamine, serotonin, norepinephrine, and epinephrine into …